SCHEMBL30876979

SCHEMBL30876979

CCCCc1nc2c(N)nc3ccsc3c2n1Cc1cccc(CO)c1

nearest known ligand 0.84

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 20/20 0.84
TLR8 Q9NR97 9/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24539571 1.00 TLR7 (0.84) TLR7TLR8
SCHEMBL24539314 0.92 TLR7 (0.80) TLR7TLR8
SCHEMBL30876996 0.92 TLR7 (0.80) TLR7TLR8
SCHEMBL30876987 0.91 TLR7 (1.00) TLR7TLR8
SCHEMBL24539489 0.91 TLR7 (1.00) TLR7TLR8
SCHEMBL24539488 0.91 TLR7 (0.84) TLR7TLR8
SCHEMBL29872110 0.90 TLR7 (1.00) TLR7TLR8
SCHEMBL24538684 0.90 TLR7 (1.00) TLR7TLR8
SCHEMBL24539645 0.90 TLR7 (0.83) TLR7TLR8
SCHEMBL24539379 0.89 TLR7 (0.84) TLR7TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240124484-A1 IMIDAZOTHIENOPYRIDINE COMPOUNDS AND METHODS OF USE ZYMEWORKS BC INC (CA) 2024-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240124484-A1 IMIDAZOTHIENOPYRIDINE COMPOUNDS AND METHODS OF USE DHFR, RARS2, DPYD TLR7 1139/4885TLR8 3109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.